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Material and Methods: Knowledge, attitudes, decisional 
conflict and preferences regarding participation in RAVES 
were measured. Predictors of trial and RAVES knowledge 
were also determined. 
 
Results: 110 men (median age = 63) eligible for RAVES were 
recruited through urologists (n=90) and radiation oncologists 
(n=20). Men preferred collaborative (34%) or semi-active 
(34%) decision-making roles. Most considered RAVES to be 
worthwhile (85%), important (81%), ‘a good thing’ (80%), 
beneficial (73%) and viewed participation as wise (76%), but 
over half (51%) had high decisional conflict regarding 
participation. Objective measures of knowledge regarding 
RCTs and RAVES were low. 
 
Conclusion: Amongst men considering management after 
prostatectomy, knowledge of RAVES was poor. Despite 
positive attitudes towards RCTs and RAVES, there was high 
decisional-conflict surrounding participation. The utility of 
decisional support materials to increase RCT knowledge and 
decrease decisional-conflict is under investigation. 
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Purpose or Objective: To assess whether both patients and 
their relatives would welcome further information on a one-
to-one basis on RT planning and delivery using the virtual 
reality (VR) system VERT. 
 
Material and Methods: One hundred and fifty patients with a 
variety of solid malignancies receiving radical RT were 
included in the study (90 prostate tumours, 52 breast 
tumours, 4 rectal tumours, 3 lung tumours and 1 thymoma). 
The study was approved by the local ethics committee. For 
each study patient, their planning CT Scan images and RT 
plan were uploaded onto the VERT system using the Digital 
Imaging and Communication in Medicine (DICOM) standard. 
Patients and relatives were shown using VERT (Figure 1) and 
on a one-to-one basis with an oncologist or a radiographer, a 
standard room where RT is given, a linear accelerator, and 
how RT is planned and delivered using their own planning CT 
Scans. Emphasis was put on the area to be treated and the 
organs around it. At the end of the exercise, patients were 
asked to fill in a questionnaire to assess their expectations. 
Radiotherapy was performed using 10 or 6 MV photons 
delivered from a Varian 2100IX linear accelerator. Treatment 
planning was performed on the ‘Eclipse’ system using CT 
scans. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results: 
 
 
 
The analysis of patients' expectations during the whole 
process of RT planning and delivery showed that 83.0% (95%CI 
76.99% to 89.01%) of patients had a moderate or high need to 
better understand using 3D imaging how RT is planned, and 
83.3% (CI 77.33% to 89.27%) of patients had a moderate or 
high need to understand using 3D imaging how RT is 
delivered. Furthermore, 80.6% (CI 74.27% to 86.93%) of 
patients had a moderate or high need to see the area to be 
treated using their own CT Scans uploaded onto the VERT 3D 
system. All respondents cited greater understanding as a 
positive outcome of the exercise. Patients welcomed this 
information as it helped them to reduce their fears about RT. 
Relatives felt also more involved in the treatment of their 
loved one. 
 
Conclusion: Providing this information using 3D imaging 
systems rather than 2D helped patients and relatives to 
better understand the complexity of RT planning and 
delivery, and reduced their anxieties. The results obtained in 
this pilot study show that VR aids could become an important 
tool for delivering information on RT to both patients and 
relatives, hence, improving patients’ experience and 
satisfaction. Further work is needed to assess whether such 
approaches improve patients’ compliance with treatment and 
whether it could ultimately impact on treatment outcome. 
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Purpose or Objective: The patient's understanding about 
radiotherapy process is necessary for safe and accurate 
delivery of radiation. We developed an education video about 
radiotherapy process. The purpose of this study was to 
evaluate the effectiveness of the education contents using 
YouTube. 
 
Material and Methods: An eleven minutes video was 
developed instructing whole radiotherapy process including 
consultation, simulation, radiotherapy treatment planning, 
verification and irradiation. After consultation for 
radiotherapy, each patient was required to see the video 
posted on YouTube through provided lab-top or tablet PC in 
our clinic. The questionnaire about patient satisfaction with 
the video and knowledge of radiotherapy was carried out by 
interviewing after watching video. Also, set up error was 
measured at the first week of verification process.  
 
Results: In clinic setting, twenty patients who visited to 
radiation oncology clinic and watched video were enrolled in 
the study. Of 20 participants, 11 (55%) rated the video as 
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'recommended' and 15 (75%) responded that the video was 
'helpful to understand radiation treatment'. After watching 
the video, average set up error at the first verification 
process was significantly decreased compared to the 
historical values of 124 patients (1.6 mm versus 2.2 mm, p = 
0.03). In web, two thousand two hundred people globally 
viewed YouTube videos about radiotherapy. 
 
Conclusion: Implementation of education video instructing 
the radiotherapy process helped to increase patient safety. 
Education based on YouTube could be an effective method 
for cancer patients. 
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Purpose or Objective: Stereotactic body radiotherapy (SBRT) 
is evolving into a standard of care in cancer management and 
consists in giving high doses of radiation to tumor deposits in 
extracranial locations. The objective of our study is to show 
our results in terms of toxicity and local response after 
implementing the technique in our department. 
 
Material and Methods: Between May 2012 to August 2015, 
120 patients (170 lesions) with body metastases or primaries 
of varying histologies were treated with SBRT. We evaluated 
acute (<3months) and late (>3months) toxicities as well as 
the response of the treated lesions. 26 patients were treated 
with a linac-based 3D conformal SBRT planning and 2 lesions 
with static IMRT. The other 142 lesions received a Volumetric 
Modulated Arc Therapy (VMAT) treatment using RA (Rapid 
Arc), 83 with flattening filter and 59 were treated without 
flattening filter (flattening filter free beam- FFF). 
 
Results: The mean age of patients was 60 years (26-87) and 
the median follow-up was 8 months (1-33). The most common 
histology was non-small cell lung cancer and the most 
frequent localizations of the treated lesions were bone 
(31.7%), lung (both metastases and primary, 22.2%), liver 
(17.1%) and lymph node metastases (14.7%); other 
localizations: 14.3%. Administered dose and fractionation 
varied significantly depending on the size and location of 
each lesion and its anatomic relationship with adjacent 
organs at risk, ranging from one to ten fractions and 8 to 
60Gy. The median volume of the PTV was 42.50cc (0.89-
259.08cc). In relation to the local response, we found 74.7% 
of complete or significant responses, 15.8% of minor 
responses or stability, 2.4% progressions and 7.1% 
pseudoprogressions. Acutely, the most frequent toxicities 
were fatigue and bone flair. There were no grade 4 toxicities 
and we identified only one grade 3 acute asthenia. 
Chronically, the most frequent side effect was bone pain 
(3.3%). 
 
Conclusion: Our series confirms excellent local control with a 
low rate of side effects when treating extracranial 
metastases with SBRT. Longer follow-up is necessary to assess 
whether the local response is maintained over time and to 
identify the factors related to SBRT treatment that may 
influence overall survival. 
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Purpose or Objective: To compare the results of low dose 
protontherapy and photodynamic therapy (PDT) for the 
treatment of circumscribed choroidal haemangiomas (CCH). 
 
Material and Methods: 48 patients (48 eyes) eyes with CCH 
were referred, treated between 1994 and 2014 and followed 
in our clinic. A historical series of 20 patients treated with 
protontherapy since 1994 was compared to 28 patients 
treated with photodynamic therapysince 2006. Tumor and 
functional outcomes were compared. Chi-squared or Fisher’s 
tests were used to establish differences between 
discontinuous variables. Student t-test or the Mann-Whitney 
U test was used to compare continuous variables. The 
Spearman test was utilized for correlations. 
 
Results: Groups were comparable for patient (age, gender) 
and disease (size, baseline complications and visual acuity) 
characteristics but neither macular location (16/20 for 
protontherapy, 9/28 for PDT, p 0.02) nor initial thickness 
(higher in the protontherapy group, p 0.02). Mean follow-up 
was 35 months (48 for protontherapy, 24 for PDT p 
0.001).There was a higher rate of retreatment for relapse 
and complications with PDT than protontherapy (p 0.044 and 
0.006, respectively).There was a non-significantly higher gain 
in visual acuity with protontherapy than PDT. There was a 
mean 67% and 32% thickness decrease with protons and PDT 
(p 0.002). 
 
Conclusion: Considering that protontherapy is more invasive 
due to clip placement and uses ionizing radiations, it cannot 
be advocated as a first hand option. However, initially 
promising results with PDT are challenged by protontherapy 
and the current series suggest that protontherapy should be 
proposed after first failure to PDT. Prospective trials are 
warranted to compare the two options as first treatment. 
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Purpose or Objective: First independent Audit to show that 
giving superficial radiotherapy (100KV Photons) is effective. 
Majority of cases (94%) did not require subsequent hand 
surgery. 
 
Material and Methods: During the period 2010 to 2015, over 
150 patients were treated by one Radiotherapist using the 
European treatment protocol of 10 treatments given over a 2 
to 3 month period (5 fractions over 1 to 2 weeks followed by 
2-month gap and then, the 5 treatments are repeated. Total 
applied dose of 30Gy). Each patient's disease is photographed 
before and after treatment, the palpable disease having been 
marked on the hands and feet in order to clearly show 
benefit achieved.  
 
Results: Independent Audit of a detailed questionnaire sent 
to patients showed 94% were satisfied with results up to 4 
years post treatment. Satisfaction composed of regression of 
disease in hands and feet and/or no further progression of 
the disease.  
 
Conclusion: Superficial radiotherapy is a highly effective and 
inexpensive treatment of Dupuytren's, provided that patients 
are referred during the early stages of the disease. Patients 
are able to continue normal use of hands (and feet) 
throughout the treatment, so their daily lives are not 
altered. General Practitioners, hand surgeons and affected 
patients should be made aware of the good results achieved 
by radiotherapy, without significant morbidity. 
 
 
 
